The cream is also easy to apply and can be used on all skin types
Dosing varies by protocol
DOSAGE AND ADMINISTRATION : DOSAGE FORMS AND STRENGTHS : Solution for subcutaneous injection, pre-filled, multi-dose pen that delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg (6 mg/mL, 3 mL) CONTRAINDICATIONS : Do not use in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2
In addition to its insulinotropic effects, GLP-1 promotes beta cell proliferation, it is involved in gastrointestinal motility, and it inhibits gastric emptying
Other digestive symptoms may include occasional vomiting (reported in 8-24% of patients), diarrhea, constipation, or abdominal discomfort
EFAs are called essential because they are critical for health but cannot be produced in sufficient quantities by the body and thus must be consumed through diet